Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=44

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03354429-sae",
        "title": "Ticagrelor vs Placebo: serious adverse events",
        "summary": "571 of 5523 against 609 of 5493; risk difference -0.7 points, 95% interval -1.9 to 0.4; NCT03354429, THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death",
        "record": "/library/comparisons/NCT03354429-sae",
        "nct_id": "NCT03354429",
        "kind": "serious-adverse-events",
        "participants": 11016,
        "risk_difference": {
          "value": -0.00748253690712776,
          "lower": -0.019045765047011443,
          "upper": 0.004073025828665276
        },
        "group_1": "571 of 5,523",
        "group_2": "609 of 5,493",
        "difference": "-0.7 points",
        "interval": "-1.9 to 0.4",
        "trial_title": "THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death"
      },
      {
        "id": "NCT02587936-deaths",
        "title": "Intervention vs Usual Care: deaths from any cause",
        "summary": "129 of 5508 against 148 of 5492; risk difference -0.4 points, 95% interval -0.9 to 0.2; NCT02587936, Improving Chronic Disease Management With Pieces",
        "record": "/library/comparisons/NCT02587936-deaths",
        "nct_id": "NCT02587936",
        "kind": "deaths",
        "participants": 11000,
        "risk_difference": {
          "value": -0.003527809116687059,
          "lower": -0.009434297658272065,
          "upper": 0.002348436377700584
        },
        "group_1": "129 of 5,508",
        "group_2": "148 of 5,492",
        "difference": "-0.4 points",
        "interval": "-0.9 to 0.2",
        "trial_title": "Improving Chronic Disease Management With Pieces"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=45",
  "request_id": "4eGP1sfN1PfxP2Rq"
}